drugset
drugset / Trial / NCT05799469

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

NCT05799469 ↗

Phase 2 Not yet recruiting 36 enrolled Chongqing University Cancer Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a single-arm, single-center, exploratory study, the purpose of this study is to evaluate the efficacy and safety of envafolimab combined with Chemoradiotherapy in participants with locally advanced cervical cancer.

Timeline

Start
2023-05-01
Primary completion
2027-05-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Envafolimab Monoclonal antibody 300 mg —
Background Cisplatin Other / unclassified 40 mg/m2 Intravenous

Indications

cervical cancer